These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 6173114
1. Dose- and schedule-dependent activation and drug synergism between thymidine and 5-aza-2'-deoxycytidine in a human promyelocytic leukemia cell line. Grant S, Rauscher F, Margolin J, Cadman E. Cancer Res; 1982 Feb; 42(2):519-24. PubMed ID: 6173114 [Abstract] [Full Text] [Related]
2. Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice. Zaharko DS, Ramonas LM. J Natl Cancer Inst; 1982 May; 68(5):875-80. PubMed ID: 6951095 [Abstract] [Full Text] [Related]
6. Differences in DNA damage produced by incorporation of 5-aza-2'-deoxycytidine or 5,6-dihydro-5-azacytidine into DNA of mammalian cells. Covey JM, D'Incalci M, Tilchen EJ, Zaharko DS, Kohn KW. Cancer Res; 1986 Nov; 46(11):5511-7. PubMed ID: 2428479 [Abstract] [Full Text] [Related]
7. Effect of deoxycytidine on the metabolism and cytotoxicity of 5-aza-2'-deoxycytidine and arabinosyl 5-azacytosine in normal and leukemic human myeloid progenitor cells. Bhalla K, Cole J, MacLaughlin W, Arlin Z, Baker M, Graham G, Grant S. Leukemia; 1987 Dec; 1(12):814-9. PubMed ID: 2447450 [Abstract] [Full Text] [Related]
10. Cytotoxic and cytokinetic effects of thymidine, 5-fluorouracil, and deoxycytidine on HeLa cells in culture. Fried J, Perez AG, Doblin JM, Clarkson BD. Cancer Res; 1981 Jul; 41(7):2627-32. PubMed ID: 7248935 [Abstract] [Full Text] [Related]
11. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools. Ross DD, Akman SA, Schrecker AW, Bachur NR. Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653 [Abstract] [Full Text] [Related]
12. Differential affinities of pyrimidine nucleoside analogues for deoxythymidine and deoxycytidine kinase determine their incorporation into murine leukemia L1210 cells. Balzarini J, De Clercq E. Acta Biochim Pol; 1987 Nov; 34(2):63-77. PubMed ID: 2823514 [Abstract] [Full Text] [Related]
14. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60. Grant S, Bhalla K, Rauscher F, Cadman E. Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943 [Abstract] [Full Text] [Related]
15. Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice. Veselý J, Cihák A. Cancer Res; 1977 Oct; 37(10):3684-9. PubMed ID: 71199 [Abstract] [Full Text] [Related]
18. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine. Kong XB, Tong WP, Chou TC. Mol Pharmacol; 1991 Feb; 39(2):250-7. PubMed ID: 1705001 [Abstract] [Full Text] [Related]
19. Biological characterization of a prolonged antileukemic effect of 5-azacytidine. Presant CA, Valeriote F, Vietti TJ. Cancer Res; 1977 Feb; 37(2):376-81. PubMed ID: 64294 [Abstract] [Full Text] [Related]
20. Phase I and pharmacokinetic study of 5-aza-2'-deoxycytidine (NSC 127716) in cancer patients. van Groeningen CJ, Leyva A, O'Brien AM, Gall HE, Pinedo HM. Cancer Res; 1986 Sep; 46(9):4831-6. PubMed ID: 2425959 [Abstract] [Full Text] [Related] Page: [Next] [New Search]